9 May 2024 - results' delay
The AIM-listed pharmaceutical group has announced yet another delay to its annual results' announcement which is clearly a concern for investors. Originally scheduled to be announced on 9 April, these were then delayed until 23 April and the 8 May. The announcement that there has been another delay for the auditors to complete their work satisfactorily is something of a surprise as we are now a month after the original date. The company has also announced the resignation of CEO Peter Butterfield although we do not believe that this is particularly significant in looking . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
